Company intelligence / Profile preview
Altheus Therapeutics, Inc.
Oklahoma City, Oklahoma, United Statesaltheustherapeutics.com ↗
- Ownership
- Private
- Employees
- ~9
- Development stage
- Other
01
Overview
Altheus completed a Phase 1 study of Zoenasa Rectal Gel with no serious adverse events reported. The company subsequently conducted a Phase 2 proof-of-concept clinical trial (ZA201) with 120 patients to evaluate the efficacy and safety of Zoenasa Rectal Gel versus mesalamine enema in patients with left-sided ulcerative colitis. The treatment portion of this trial was completed in February 2014.
- Therapeutic areas
- Gastroenterology
- Modalities
- Small moleculesfixed-dose combination therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Altheus Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altheus Therapeutics, Inc..